BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2419504)

  • 21. Inhibition of serotonin biosynthesis by 6-halotryptophans in vivo.
    Peters DA
    Biochem Pharmacol; 1971 Jul; 20(7):1413-20. PubMed ID: 5163081
    [No Abstract]   [Full Text] [Related]  

  • 22. How important is the synthesis of brain 5-hydroxytryptamine in the physiological control of its central function?
    Grahame-Smith DG
    Adv Biochem Psychopharmacol; 1974; 10():83-91. PubMed ID: 4367772
    [No Abstract]   [Full Text] [Related]  

  • 23. Caffeine injection raises brain tryptophan level, but does not stimulate the rate of serotonin synthesis in rat brain.
    Fernstrom MH; Bazil CW; Fernstrom JD
    Life Sci; 1984 Sep; 35(12):1241-7. PubMed ID: 6207403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a selective 5-HT uptake inhibitor--Lu 10-171--on rat brain 5-HT turnover.
    Hyttel J
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):439-46. PubMed ID: 139078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of biochemical indices of 5-hydroxytryptaminergic neuronal activity following electrical stimulation of the dorsal raphe nucleus.
    Shannon NJ; Gunnet JW; Moore KE
    J Neurochem; 1986 Sep; 47(3):958-65. PubMed ID: 2426412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
    Mueller RA; Towle A; Breese GR
    Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of the anticonvulsant valproic acid on cerebral indole amine metabolism.
    MacMillan V
    Can J Physiol Pharmacol; 1979 Aug; 57(8):843-7. PubMed ID: 387187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonparallel changes in brain monoamines of pyridoxine-deficient growing rats.
    Dakshinamurti K; LeBlancq WD; Herchl R; Havlicek V
    Exp Brain Res; 1976 Nov; 26(4):355-66. PubMed ID: 1001386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feedback control of rat brain 5-hydroxytryptamine synthesis.
    Macon JB; Sokoloff L; Glowinski J
    J Neurochem; 1971 Mar; 18(3):323-31. PubMed ID: 5314774
    [No Abstract]   [Full Text] [Related]  

  • 30. Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.
    Bartholini G; Da Prada M; Pletscher A
    J Pharm Pharmacol; 1968 Mar; 20(3):228-9. PubMed ID: 4385052
    [No Abstract]   [Full Text] [Related]  

  • 31. Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction.
    Lacković Z; Salković M
    Life Sci; 1990; 46(1):49-54. PubMed ID: 1688991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual action of methadone on 5-HT synthesis and metabolism.
    Ahtee L; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1979 May; 307(1):51-6. PubMed ID: 314596
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of ethanol on the in vivo conversion of 5-HTP-14C to serotonin-14C, 5-hydroxyindoleacetaldehyde-14C and its metabolites in rat brain.
    Feldstein A; Sidel CM
    Int J Neuropharmacol; 1969 Jul; 8(4):347-51. PubMed ID: 5307042
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of enzymes that synthesize neurotransmitter monoamines.
    Fuller RW; Steinberg M
    Adv Enzyme Regul; 1976; 14():347-390. PubMed ID: 9790
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of antidepressants on serotonin turnover in discrete regions of rat brain.
    Marco EJ; Meek JL
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):75-9. PubMed ID: 311440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of drugs on serotonergic nerve terminals.
    Bloom FE; Costa E
    Adv Cytopharmacol; 1971 May; 1():379-95. PubMed ID: 5163249
    [No Abstract]   [Full Text] [Related]  

  • 37. 5-Hydroxytryptophol and 5-hydroxyindoleacetic acid levels in rat brain: effects of various drugs affecting serotonergic transmitter mechanisms.
    Beck O; Lundman A; Jonsson G
    J Neural Transm; 1987; 69(3-4):287-98. PubMed ID: 2442302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake of 14C-labelled 5-hydroxytryptophan and 5-hydroxytryptamine by separated rat renal tubules.
    Inagaki C
    Jpn J Pharmacol; 1977 Feb; 27(1):79-86. PubMed ID: 301211
    [No Abstract]   [Full Text] [Related]  

  • 39. Phenelzine-induced convulsions and alterations in the conversion of 5-HTP-14C to serotonin-14C in vivo.
    Feldstein A; Sidel CM
    Biochem Pharmacol; 1966 Jan; 15(1):111-7. PubMed ID: 5296089
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.